Adam Logal

Biography

 Mr. Logal has served as OPKO’s Sr. Vice President and Chief Financial Officer since March 2014 and he served as OPKO’s Vice President of Finance, Chief Accounting Officer and Treasurer from July 2012 until March 2014 and as OPKO’s Director of Finance, Chief Accounting Officer and Treasurer from March 2007 until July 2012. He currently serves on the board of directors of VBI Vaccines, Inc. (NASDAQ:VBIV), a commercial-stage biopharmaceutical which develops, produces and markets next generation of vaccines to address unmet needs in infectious disease and immuno-oncology. From 2002 to 2007, Mr. Logal served in senior management of Nabi Biopharmaceuticals, a publicly traded, biopharmaceutical company engaged in the development and commercialization of proprietary products. Mr. Logal held various positions of increasing responsibility at Nabi Biopharmaceuticals, last serving as Senior Director of Accounting and Reporting.  

Research Interest

 Biopharmaceutical,Accounting,Finance